Physician profile
J David Sule
NPI 1437130515
$10,821.83
in general payments reported to CMS, 2019-2025
31 companies · $5,464 in 2025
The $5,464 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $133 · 2021: $245 · 2022: $3,242 · 2023: $348 · 2024: $1,105 · 2025: $5,464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,016 · Food and Beverage: $2,619 · Travel and Lodging: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,016.32 |
| Food and Beverage | $2,618.69 |
| Travel and Lodging | $1,282.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,670.14 | 2022-2025 | |
| Boston Scientific Corporation | $1,071.56 | 2019-2025 | Lithovue, Rezum Generator, Spaceoar Vue System - 10ml |
| Procept Biorobotics Corporation | $1,013.08 | 2022-2025 | Aquabeam System |
| Urogen Pharma, INC. | $506.03 | 2024-2025 | |
| Coloplast Corp | $225.50 | 2021-2025 | Titan |
| Pfizer INC. | $180.36 | 2021-2025 | |
| Abbvie INC. | $140.03 | 2022-2025 | |
| Urovant Sciences INC | $134.80 | 2021-2022 | |
| Astellas Pharma US INC | $123.74 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $84.89 | 2023 | Gemtesa, Orgovyx |
| Medtronic USA, INC. | $84.35 | 2019 | |
| Myovant Sciences INC. | $70.99 | 2021-2022 | |
| Microline Surgical INC | $69.11 | 2025 | |
| Uroviu Corporation | $44.62 | 2023 | Uro-G Flexible Cystoscope |
| Valencia Technologies Corporation | $41.70 | 2025 | Ecoin Device Kit |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $39.20 | 2024 | Xiaflex |
| Endo Pharmaceuticals INC. | $38.01 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $32.99 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Janssen Biotech, INC. | $32.36 | 2023 | Erleada |
| Merck Sharp & Dohme LLC | $29.29 | 2023 | Keytruda, Lynparza |
| Braintree Laboratories, INC. | $25.14 | 2023 | Suflave |
| Takeda Pharmaceuticals U.S.A., INC. | $23.87 | 2023 | Entyvio |
| Emd Serono, INC. | $20.14 | 2023 | Mavenclad |
| Xeris Pharmaceuticals, INC. | $18.62 | 2024 | Keveyis |
| Medtronic, INC. | $18.05 | 2024 | Interstim |
| Olympus America INC. | $17.40 | 2025 | Itind System |
| Celgene Corporation | $17.15 | 2023 | |
| Allergan, INC. | $15.23 | 2021 | |
| Intercept Pharmaceuticals, INC. | $14.87 | 2022 | |
| Convatec INC. | $14.79 | 2023 | |
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw J Sule listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.